Completed PHASE3 INTERVENTIONAL 4-arm NCT00116493

Severe Anemia Treatment Trials, Pakistan

Evaluation of Anthelminthics and Multivitamins for Treatment of Severe Anemia in Pregnant Women and Children 6-24 Months of Age in Pakistan

Sponsor: Aga Khan University

Conditions Anemia

Interventions Iron-folic acid and mebendazole Mebendazole Mebendazole + Multivitamin Multivitamins

Updated 5 times since 2017 Last updated: Apr 6, 2012 Started: Apr 30, 2004 Primary completion: May 31, 2007 Completion: May 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Anemia and is currently completed. Aga Khan University leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aga Khan University
Johns Hopkins Bloomberg School of Public Health

Data source: Johns Hopkins Bloomberg School of Public Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan